1. Home
  2. DVAX vs GTY Comparison

DVAX vs GTY Comparison

Compare DVAX & GTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DVAX
  • GTY
  • Stock Information
  • Founded
  • DVAX 1996
  • GTY 1955
  • Country
  • DVAX United States
  • GTY United States
  • Employees
  • DVAX N/A
  • GTY N/A
  • Industry
  • DVAX Biotechnology: Pharmaceutical Preparations
  • GTY Real Estate
  • Sector
  • DVAX Health Care
  • GTY Finance
  • Exchange
  • DVAX Nasdaq
  • GTY Nasdaq
  • Market Cap
  • DVAX 1.7B
  • GTY 1.8B
  • IPO Year
  • DVAX 2004
  • GTY N/A
  • Fundamental
  • Price
  • DVAX $12.90
  • GTY $32.14
  • Analyst Decision
  • DVAX Buy
  • GTY Buy
  • Analyst Count
  • DVAX 2
  • GTY 3
  • Target Price
  • DVAX $22.00
  • GTY $33.33
  • AVG Volume (30 Days)
  • DVAX 1.3M
  • GTY 217.4K
  • Earning Date
  • DVAX 11-07-2024
  • GTY 02-12-2025
  • Dividend Yield
  • DVAX N/A
  • GTY 5.83%
  • EPS Growth
  • DVAX N/A
  • GTY N/A
  • EPS
  • DVAX 0.15
  • GTY 1.16
  • Revenue
  • DVAX $260,810,000.00
  • GTY $198,017,000.00
  • Revenue This Year
  • DVAX $21.64
  • GTY N/A
  • Revenue Next Year
  • DVAX $19.81
  • GTY $9.68
  • P/E Ratio
  • DVAX $85.33
  • GTY $27.81
  • Revenue Growth
  • DVAX N/A
  • GTY 9.20
  • 52 Week Low
  • DVAX $9.74
  • GTY $25.70
  • 52 Week High
  • DVAX $15.01
  • GTY $33.85
  • Technical
  • Relative Strength Index (RSI)
  • DVAX 57.32
  • GTY 48.67
  • Support Level
  • DVAX $12.66
  • GTY $31.82
  • Resistance Level
  • DVAX $13.17
  • GTY $32.64
  • Average True Range (ATR)
  • DVAX 0.29
  • GTY 0.50
  • MACD
  • DVAX -0.04
  • GTY -0.07
  • Stochastic Oscillator
  • DVAX 48.08
  • GTY 15.76

About DVAX Dynavax Technologies Corporation

Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.

About GTY Getty Realty Corporation

Getty Realty Corp is the real estate investment trust in the U.S. specializing in the acquisition, financing, and development of convenience, automotive, and other single tenant retail real estate. The company's portfolio includes convenience stores, car washes, automotive service centers (gasoline and repair, oil and maintenance, tire and battery, collision), automotive parts retailers, and certain other freestanding retail properties, including drive-thru quick service restaurants. It generates majority of the revenue in the form of rental income.

Share on Social Networks: